| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 146, Issue 10 3656-3661, Copyright © 1991 by American Association of Immunologists
ARTICLES |
S Grabbe, S Bruvers, RL Gallo, TL Knisely, R Nazareno and RD Granstein
Wellman Laboratories of Photomedicine, Harvard Medical School, Boston, MA 02114.
The ability of epidermal Langerhans cells to present Ag for CD4- dependent immunity is well documented, and it has been hypothesized that Langerhans cells participate in the generation of immunity against incipient epidermal neoplasms by presentation of tumor-associated Ag in situ. This study examined the ability of murine epidermal cells (EC) to present tumor-associated Ag for the induction of in vivo antitumor immunity. Murine epidermal cells were deleted of Thy-1-bearing cells, cultured in 50 U/ml granulocyte-macrophage-CSF for 14 to 18 h, and pulsed with tumor fragments (TF) derived from S1509a-fibrosarcoma cells. These TF-pulsed EC were injected s.c. into syngeneic recipients at weekly intervals for a total of three immunizations and challenged with viable S1509a tumor cells 1 wk after the last immunization. Control animals received TF-pulsed allogeneic EC or EC treated identically but not pulsed with TF. EC that were pulsed with tumor cell fragments were able to induce protective immunity to tumor growth in vivo and to immunize for a significant delayed-type hypersensitivity response to injected tumor cells. The induction of antitumor immunity with TF-pulsed EC was genetically restricted, and culture of EC in granulocyte-macrophage-CSF was required for development of significant immunity. Furthermore, deletion of I-A+ cells by antibody and complement-mediated lysis eliminated the generation of immunity. Thus, I-A+ epidermal cells are capable of presenting S1509a tumor Ag for the generation of protective antitumor immunity in vivo.
This article has been cited by other articles:
|
|
 |
|
  P. Stoitzner, L. K. Green, J. Y. Jung, K. M. Price, C. H. Tripp, B. Malissen, A. Kissenpfennig, I. F. Hermans, and F. Ronchese Tumor Immunotherapy by Epicutaneous Immunization Requires Langerhans Cells J. Immunol., February 1, 2008; 180(3): 1991 - 1998. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Cools, P. Ponsaerts, V. F. I. Van Tendeloo, and Z. N. Berneman Balancing between immunity and tolerance: an interplay between dendritic cells, regulatory T cells, and effector T cells J. Leukoc. Biol., December 1, 2007; 82(6): 1365 - 1374. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Loser, J. Apelt, M. Voskort, M. Mohaupt, S. Balkow, T. Schwarz, S. Grabbe, and S. Beissert IL-10 Controls Ultraviolet-Induced Carcinogenesis in Mice J. Immunol., July 1, 2007; 179(1): 365 - 371. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Bennaceur, I. Popa, J. Portoukalian, O. Berthier-Vergnes, and J. Peguet-Navarro Melanoma-derived gangliosides impair migratory and antigen-presenting function of human epidermal Langerhans cells and induce their apoptosis Int. Immunol., June 1, 2006; 18(6): 879 - 886. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. D. Granstein, W. Ding, J. Huang, A. Holzer, R. L. Gallo, A. Di Nardo, and J. A. Wagner Augmentation of Cutaneous Immune Responses by ATP{gamma}S: Purinergic Agonists Define a Novel Class of Immunologic Adjuvants J. Immunol., June 15, 2005; 174(12): 7725 - 7731. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Loser, A. Scherer, M. B. W. Krummen, G. Varga, T. Higuchi, T. Schwarz, A. H. Sharpe, S. Grabbe, J. A. Bluestone, and S. Beissert An Important Role of CD80/CD86-CTLA-4 Signaling during Photocarcinogenesis in Mice J. Immunol., May 1, 2005; 174(9): 5298 - 5305. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Bonnotte, M. Gough, V. Phan, A. Ahmed, H. Chong, F. Martin, and R. G. Vile Intradermal Injection, as Opposed to Subcutaneous Injection, Enhances Immunogenicity and Suppresses Tumorigenicity of Tumor Cells Cancer Res., May 1, 2003; 63(9): 2145 - 2149. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Seiffert, J. Hosoi, H. Torii, H. Ozawa, W. Ding, K. Campton, J. A. Wagner, and R. D. Granstein Catecholamines Inhibit the Antigen-Presenting Capability of Epidermal Langerhans Cells J. Immunol., June 15, 2002; 168(12): 6128 - 6135. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Prabakaran, C. Menon, S. Xu, A. Gomez-Yafal, B. J. Czerniecki, and D. L. Fraker Mature CD83+ Dendritic Cells Infected With Recombinant gp100 Vaccinia Virus Stimulate Potent Antimelanoma T Cells Ann. Surg. Oncol., May 1, 2002; 9(4): 411 - 418. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Beissert, D. Ruhlemann, T. Mohammad, S. Grabbe, A. El-Ghorr, M. Norval, H. Morrison, R. D. Granstein, and T. Schwarz IL-12 Prevents the Inhibitory Effects of cis-Urocanic Acid on Tumor Antigen Presentation by Langerhans Cells: Implications for Photocarcinogenesis J. Immunol., December 1, 2001; 167(11): 6232 - 6238. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Terheyden, P. t. Straten, E.-B. Brocker, E. Kampgen, and J. C. Becker CD40-Ligated Dendritic Cells Effectively Expand Melanoma-Specific CD8+ CTLs and CD4+ IFN-{gamma}-Producing T Cells from Tumor-Infiltrating Lymphocytes J. Immunol., June 15, 2000; 164(12): 6633 - 6639. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Tada, A. Asahina, K. Nakamura, M. Tomura, H. Fujiwara, and K. Tamaki Granulocyte/Macrophage Colony-Stimulating Factor Inhibits IL-12 production of Mouse Langerhans Cells J. Immunol., May 15, 2000; 164(10): 5113 - 5119. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Yang, D. Kittlesen, C. L. Slingluff Jr., C. E. Vervaert, H. F. Seigler, and T. L. Darrow Dendritic Cells Infected with a Vaccinia Vector Carrying the Human gp100 Gene Simultaneously Present Multiple Specificities and Elicit High-Affinity T Cells Reactive to Multiple Epitopes and Restricted by HLA-A2 and -A3 J. Immunol., April 15, 2000; 164(8): 4204 - 4211. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K Denzer, M. Kleijmeer, H. Heijnen, W Stoorvogel, and H. Geuze Exosome: from internal vesicle of the multivesicular body to intercellular signaling device J. Cell Sci., January 10, 2000; 113(19): 3365 - 3374. [Abstract] [PDF]
|
|
|
|
|
|
S. Beissert, J. A. Bluestone, I. Mindt, M. Voskort, D. Metze, A. Mehling, T. A. Luger, T. Schwarz, and S. Grabbe Reduced Ultraviolet-Induced Carcinogenesis in Mice with a Functional Disruption in B7-Mediated Costimulation J. Immunol., December 15, 1999; 163(12): 6725 - 6731. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Yamazaki, T. Nguyen, and E. R. Podack Cutting Edge: Tumor Secreted Heat Shock-Fusion Protein Elicits CD8 Cells for Rejection J. Immunol., November 15, 1999; 163(10): 5178 - 5182. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Chiodoni, P. Paglia, A. Stoppacciaro, M. Rodolfo, M. Parenza, and M. P. Colombo Dendritic Cells Infiltrating Tumors Cotransduced with Granulocyte/Macrophage Colony-stimulating Factor (GM-CSF) and CD40 Ligand Genes Take Up and Present Endogenous Tumor-associated Antigens, and Prime Naive Mice for a Cytotoxic T Lymphocyte Response J. Exp. Med., July 5, 1999; 190(1): 125 - 134. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Curiel-Lewandrowski, K. Mahnke, M. Labeur, B. Roters, W. Schmidt, R. D. Granstein, T. A. Luger, T. Schwarz, and S. Grabbe Transfection of Immature Murine Bone Marrow-Derived Dendritic Cells with the Granulocyte-Macrophage Colony-Stimulating Factor Gene Potently Enhances Their In Vivo Antigen-Presenting Capacity J. Immunol., July 1, 1999; 163(1): 174 - 183. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Labeur, B. Roters, B. Pers, A. Mehling, T. A. Luger, T. Schwarz, and S. Grabbe Generation of Tumor Immunity by Bone Marrow-Derived Dendritic Cells Correlates with Dendritic Cell Maturation Stage J. Immunol., January 1, 1999; 162(1): 168 - 175. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kocikova, A. Kolesaric, F. Koszik, G. Stingl, and A. Elbe-Burger Murine Langerhans Cells Cultured Under Serum-Free Conditions Mature into Potent Stimulators of Primary Immune Responses In Vitro and In Vivo J. Immunol., October 15, 1998; 161(8): 4033 - 4041. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. K. Shreedhar, M. W. Pride, Y. Sun, M. L. Kripke, and F. M. Strickland Origin and Characteristics of Ultraviolet-B Radiation-Induced Suppressor T Lymphocytes J. Immunol., August 1, 1998; 161(3): 1327 - 1335. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. N.J. Hart Dendritic Cells: Unique Leukocyte Populations Which Control the Primary Immune Response Blood, November 1, 1997; 90(9): 3245 - 3287. [Full Text] [PDF]
|
|
|
|
|
|
W. Song, H.-L. Kong, H. Carpenter, H. Torii, R. Granstein, S. Rafii, M. A.S. Moore, and R. G. Crystal Dendritic Cells Genetically Modified with an Adenovirus Vector Encoding the cDNA for a Model Antigen Induce Protective and Therapeutic Antitumor Immunity J. Exp. Med., October 20, 1997; 186(8): 1247 - 1256. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. I. Mayordomo, T. Zorina, W. J. Storkus, L. Zitvogel, M. D. Garcia-Prats, A. B. DeLeo, and M. T. Lotze Bone Marrow-Derived Dendritic Cells Serve as Potent Adjuvants for Peptide-Based Antitumor Vaccines Stem Cells, March 1, 1997; 15(2): 94 - 103. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. Siena, M. Di Nicola, R. Mortarini, A. Anichini, M. Bregni, G. Parmiani, and A. M. Gianni Expansion of Immunostimulatory Dendritic Cells from Peripheral Blood of Patients with Cancer Oncologist, February 1, 1997; 2(1): 65 - 69. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
